1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Gilead Sciences Health Access Grants in U.S. is sponsored by Gilead Sciences, Inc.. U.S. tax-exempt nonprofits focused on health care access and delivery can seek program support for HIV, liver disease, oncology, and inflammatory or respiratory disease initiatives. This funding is for community-informed, data-driven projects that strengthen care infrastructure, advance health equity, and provide education for vulnerable populations.
Remote patient monitoring within these disease areas would be a strong fit.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the opportunity page linked on this listing to help you evaluate fit faster.
Gilead Sciences: How to Apply for Grant Funding We partner with patient advocates, nonprofits, and healthcare professionals across our core therapeutic areas to improve care through community engagement. By supporting community-informed, data-driven programs, we help strengthen healthcare infrastructure, expand education and provide financial support to the most vulnerable populations.
Our corporate giving focuses on where the need is greatest, prioritizing initiatives with a clear ability to deliver meaningful outcomes. Patient Community Support We strive to advance health equity, diversity in clinical trials and access to medicines to reduce disparities. We also support the local communities in which we operate.
We welcome funding requests for innovative, high-impact projects that relate to at least one of our core therapeutic areas: Primary biliary cholangitis Chronic Inflammatory Diseases Many individuals face barriers to accessing healthcare due to age, disability, ethnicity or race, location, gender, gender identity or socioeconomic status.
To help ensure all people have the opportunity to get the best possible care – regardless of background – Gilead sponsors select events or conferences that raise awareness and support organizations working in our therapeutic areas of focus. Please see our sponsorships FAQ for more information .
We work with patient advocates, nonprofits, and healthcare professionals across all our therapeutic areas of focus to improve care through partnerships and community engagement. Latin America & the Caribbean
According to the current listing, eligibility includes: U.S. tax-exempt nonprofits focused on health care access and delivery. Confirm the full requirements in the official notice before applying.
Gilead Sciences Health Access Grants in U.S. is funded by Gilead Sciences, Inc.. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Health Equity Grants is sponsored by Gilead Sciences, Inc.. Gilead Sciences provides funding to U.S. tax-exempt nonprofits focused on HIV, liver disease, oncology, or inflammatory and respiratory conditions. This funding supports education, screening, care pathways, and community-informed, data-driven initiatives to improve health equity and access to care for health disparities organizations.
Gilead COMPASS Initiative: Capacity Building and Health Equity is a grant from Gilead Sciences that funds organizations across 12 Southern US states working to control and prevent HIV among marginalized communities, including Black, Brown, Indigenous, LGBTQ+, and gender-diverse populations. The COMPASS Coordinating Centers administer four grant mechanisms: Capacity Building grants, SPARK! grants, ACTION grants, Faith Action & Congregational Partner grants, and Transformative Grants, each targeting different programmatic needs and organizational stages. Transformative Grants support development and implementation of comprehensive HIV programs. Eligible applicants are organizations based in one of the 12 Southern states served by the COMPASS Initiative. Awards are up to $100,000, with amounts varying by grant type. Application cycles vary; check the Gilead COMPASS website for current open opportunities.
HAVI's 2026 round put $10 million into 19 projects selected from 501 proposals across 42 countries, bringing the two-year total past $21 million. The open-source release requirement and the development-award feeder tier tell you more about how to win than the acceptance rate does.
Read articleThe U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read articleSchmidt Sciences opened a 'Scaling AI Safety for a Multi-Agent World' program with awards up to $1 million and an August 8, 2026 deadline. Against a backdrop of federal research slowdowns, here is why private science philanthropy matters more than ever, how these funders differ from federal agencies, and how researchers should approach them.
Read article